Table 2.
No | Checklists | Were the samples representative? | Was the sample size adequate? | Was the exposure measured in a valid and reliable way? | Was appropriate statistical analysis used? | Were confounding factors identified? | Were strategies to deal with confounding factors stated? | Were the outcomes measured in a valid and reliable way? | Was the response rate acceptable | Overall appraisal score |
---|---|---|---|---|---|---|---|---|---|---|
1 | Tsegaye et al. [28] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
2 | Abebe T et al. [18] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 6 |
3 | Hanna D et al. [8] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 7 |
4 | Tarkie et al. [27] | 1 | 1 | 1 | 1 | N/A | N/A | 1 | N/A | 5 |
5 | Hunchak et al. [24] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | N/A | 7 |
6 | Woyessa A et al. [29] | 1 | 1 | 1 | 1 | N/A | N/A | 1 | 1 | 6 |
7 | Abebe F et al. [17] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
8 | Dode et al. [21] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
9 | Jofira et al. [25] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
10 | Habte T et al. [19] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
11 | Agerie et al. [30] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
12 | Fitsumbirhan et al. [23] | 1 | 1 | 1 | 1 | N/A | N/A | 1 | N/A | 5 |
13 | Fikadu A et al. [22] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
14 | Birhan et al. [20] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
15 | Mamo et al. [26] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
16 | Tesfaye et al. [32] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 |
17 | Nigussie et al. [31] | 1 | 1 | 1 | 1 | N/A | N/A | 1 | 1 | 6 |
Note 1 = Yes 0 = No U = Unclear N/A = Not applicable